Earnings Scheduled For August 10, 2022
Companies Reporting Before The Bell
• Wix.com (NASDAQ:WIX) is estimated to report earnings for its second quarter.
SVB Leerink Maintains Outperform on Ascendis Pharma, Lowers Price Target to $174
SVB Leerink analyst Joseph Schwartz maintains Ascendis Pharma (NASDAQ:ASND) with a Outperform and lowers the price target from $193 to $174.
Morgan Stanley Maintains Overweight on Ascendis Pharma, Raises Price Target to $197
Morgan Stanley maintains Ascendis Pharma (NASDAQ:ASND) with a Overweight and raises the price target from $180 to $197.
B of A Securities Upgrades Ascendis Pharma to Buy, Raises Price Target to $161
B of A Securities analyst Tazeen Ahmad upgrades Ascendis Pharma (NASDAQ:ASND) from Neutral to Buy and raises the price target from $148 to $161.
SVB Leerink Maintains Outperform on Ascendis Pharma, Raises Price Target to $193
SVB Leerink analyst Joseph Schwartz maintains Ascendis Pharma (NASDAQ:ASND) with a Outperform and raises the price target from $190 to $193.
Credit Suisse Maintains Outperform on Ascendis Pharma, Raises Price Target to $194
Credit Suisse analyst Tiago Fauth maintains Ascendis Pharma (NASDAQ:ASND) with a Outperform and raises the price target from $188 to $194.
Expert Ratings For Ascendis Pharma
Within the last quarter, Ascendis Pharma (NASDAQ:ASND) has observed the following analyst ratings:
Wedbush Maintains Outperform on Ascendis Pharma, Lowers Price Target to $117
Wedbush analyst Liana Moussatos maintains Ascendis Pharma (NASDAQ:ASND) with a Outperform and lowers the price target from $128 to $117.
Earnings Scheduled For March 2, 2022
Companies Reporting Before The Bell
• SIGNA Sports United (NYSE:SSU) is expected to report quarterly loss at $0.04 per share on revenue of $283.61 million.